Literature DB >> 12438225

Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors.

Essi L J Hiltunen1, Maarit Anttila, Anne Kultti, Kirsi Ropponen, Jorma Penttinen, Merja Yliskoski, Arja T Kuronen, Matti Juhola, Raija Tammi, Markku Tammi, Veli-Matti Kosma.   

Abstract

The concentration and histological distribution of hyaluronan, a tumor promoting extracellular matrix polysaccharide, and the activity of hyaluronidase, a potential source of angiogenic hyaluronan oligosaccharides, were analyzed in malignant epithelial (n = 24), borderline (n = 8), benign epithelial (n = 20), functional cyst (n = 21), and normal (n = 5) tissue samples of human ovary. Hyaluronan concentration increased specifically in cancers (P = 0.001), particularly in grade 3 tumors (>49-fold) and in metastases (>89-fold). Hyaluronan staining in the tissues correlated with hyaluronan concentration (P = 0.002). Hyaluronidase activity slightly decreased from semimalignant through low grade to high grade tumors (P = 0.041). Therefore, hyaluronan accumulation, but not hyaluronidase activation, is associated with the aggressiveness of ovarian epithelial cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438225

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  39 in total

1.  Role of CD44 in the organization of keratinocyte pericellular hyaluronan.

Authors:  Sanna Pasonen-Seppänen; Juha M T Hyttinen; Kirsi Rilla; Tiina Jokela; Paul W Noble; Markku Tammi; Raija Tammi
Journal:  Histochem Cell Biol       Date:  2011-11-10       Impact factor: 4.304

2.  Tissue distribution and subcellular localization of hyaluronan synthase isoenzymes.

Authors:  Kari Törrönen; Kaisa Nikunen; Riikka Kärnä; Markku Tammi; Raija Tammi; Kirsi Rilla
Journal:  Histochem Cell Biol       Date:  2013-09-22       Impact factor: 4.304

Review 3.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

4.  Human Keratinocytes Respond to Extracellular UTP by Induction of Hyaluronan Synthase 2 Expression and Increased Hyaluronan Synthesis.

Authors:  Tiina Jokela; Riikka Kärnä; Leena Rauhala; Genevieve Bart; Sanna Pasonen-Seppänen; Sanna Oikari; Markku I Tammi; Raija H Tammi
Journal:  J Biol Chem       Date:  2017-02-10       Impact factor: 5.157

5.  Rab10-mediated endocytosis of the hyaluronan synthase HAS3 regulates hyaluronan synthesis and cell adhesion to collagen.

Authors:  Ashik Jawahar Deen; Kirsi Rilla; Sanna Oikari; Riikka Kärnä; Genevieve Bart; Jukka Häyrinen; Avinash Rahul Bathina; Antti Ropponen; Katri Makkonen; Raija H Tammi; Markku I Tammi
Journal:  J Biol Chem       Date:  2014-02-07       Impact factor: 5.157

6.  Melanoma cell-derived factors stimulate hyaluronan synthesis in dermal fibroblasts by upregulating HAS2 through PDGFR-PI3K-AKT and p38 signaling.

Authors:  Sanna Pasonen-Seppänen; Piia Takabe; Michael Edward; Leena Rauhala; Kirsi Rilla; Markku Tammi; Raija Tammi
Journal:  Histochem Cell Biol       Date:  2012-07-24       Impact factor: 4.304

7.  HAS3-induced accumulation of hyaluronan in 3D MDCK cultures results in mitotic spindle misorientation and disturbed organization of epithelium.

Authors:  Kirsi Rilla; Sanna Pasonen-Seppänen; Riikka Kärnä; Hannu M Karjalainen; Kari Törrönen; Ville Koistinen; Markku I Tammi; Raija H Tammi; Terhi Teräväinen; Aki Manninen
Journal:  Histochem Cell Biol       Date:  2011-12-08       Impact factor: 4.304

8.  Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides.

Authors:  Miranda P Ween; Katja Hummitzsch; Raymond J Rodgers; Martin K Oehler; Carmela Ricciardelli
Journal:  Clin Exp Metastasis       Date:  2010-12-12       Impact factor: 5.150

9.  Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma.

Authors:  Timo K Nykopp; Kirsi Rilla; Markku I Tammi; Raija H Tammi; Reijo Sironen; Kirsi Hämäläinen; Veli-Matti Kosma; Seppo Heinonen; Maarit Anttila
Journal:  BMC Cancer       Date:  2010-09-27       Impact factor: 4.430

10.  HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer.

Authors:  Mario W Kramer; Roozbeh Golshani; Axel S Merseburger; Judith Knapp; Alfredo Garcia; Joerg Hennenlotter; Robert C Duncan; Mark S Soloway; Merce Jorda; Marcus A Kuczyk; Arnulf Stenzl; Vinata B Lokeshwar
Journal:  Eur Urol       Date:  2009-03-31       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.